MCNAY JOSEPH C 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Apr 2, 2018
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Conversion
Common Stock
2018-03-29$0.06/sh+1,044,560$62,674→ 2,868,162 total - Conversion
Convertible Promissory Note (right to buy)
2018-03-29−1,044,560→ 0 totalExercise: $0.06From: 2013-03-29Exp: 2018-03-29→ Common Stock (1,044,560 underlying)
Footnotes (1)
- [F1]The Convertible Promissory Note in the principal amount of $50,000 accrued $12,673.60 in interest and both principal and interest were converted into 1,044,560 shares of common stock at a conversion price of $0.06 per share.